Search

Home > Biotech 2050 Podcast > 9. The next frontier in cancer treatment: Foghorn Therapeutics and Chromatin Dysregulation
Podcast: Biotech 2050 Podcast
Episode:

9. The next frontier in cancer treatment: Foghorn Therapeutics and Chromatin Dysregulation
Category: Science & Medicine
Duration: 00:27:13
Publish Date: 2020-01-23 14:50:55
Description: Carl P. Decicco is a biopharmaceutical veteran with over 30+ years of experience in the industry. Over the course of his career, Carl has played a central role in the advancement of more than 200 compounds into clinical trials and the approval of more than 20 drugs across multiple therapeutic areas. He’s authored/Co-Authored more than 100 scientific papers in peer reviewed journals and is listed as an inventor on 26 patents.
Total Play: 0